comparemela.com

Promega Gmb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioLabs and Promega Announce Collaboration to Support Young Biotech Companies

BioLabs and Promega Announce Collaboration to Support Young Biotech Companies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Promega Corporation: BioLabs and Promega Announce Collaboration to Support Young Biotech Companies

Promega Corporation: BioLabs and Promega Announce Collaboration to Support Young Biotech Companies
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

BioLabs and Promega collaborate to support young biotech companies worldwide

BioLabs and Promega collaborate to support young biotech companies worldwide
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections | Virology Journal

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered the worldwide coronavirus disease 2019 (COVID-19) pandemic. Serological assays for the detection of SARS-CoV-2 infections are important to understand the immune response in patients and to obtain epidemiological data about the number of infected people, especially to identify asymptomatic persons not aware of a past infection. We recombinantly produced SARS-CoV-2 nucleocapsid (N)-protein in Escherichia coli. We used the purified protein to develop an indirect enzyme-linked immunosorbent assay (ELISA) for the detection of SARS-CoV-2 specific antibodies. This ELISA method was optimized and validated with serum samples collected from 113 patients with RT-PCR-confirmed SARS-CoV-2 infections including hospitalized COVID-19 patients and 1500 control sera mostly collected before 2015 with different clinical background. The optimized N-protein-ELISA provided a sensitivity of 89.7% (n = 68) for samples co

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.